Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
21,96 USD | +3,10% | +11,19% | +264,18% |
Attività
Numero di dipendenti: 50
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Kevin Lind
CEO | Chief Executive Officer | 47 | 03/01/20 |
Brandi Roberts
DFI | Director of Finance/CFO | 50 | 01/01/21 |
Chief Tech/Sci/R&D Officer | - | - | |
Dewey McLin
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Operating Officer | - | - | |
Randall Kaye
CTO | Chief Tech/Sci/R&D Officer | 62 | 21/03/22 |
Julie Baker
PRN | Corporate Officer/Principal | - | 01/01/23 |
Gus Cardenas
PRN | Corporate Officer/Principal | - | - |
Anne Danks
PRN | Corporate Officer/Principal | - | - |
Marco Peters
PRN | Corporate Officer/Principal | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Paul Sekhri
CHM | Chairman | 66 | 01/12/20 |
Director/Board Member | 68 | 01/12/20 | |
Vincent Aurentz
BRD | Director/Board Member | 56 | 01/02/20 |
Casey Lynch
BRD | Director/Board Member | 50 | 01/02/21 |
Kevin Lind
CEO | Chief Executive Officer | 47 | 03/01/20 |
Corinne Le Goff
BRD | Director/Board Member | 58 | 01/03/21 |
Jane Tiller
BRD | Director/Board Member | 59 | 15/11/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 0 | 2 420 755 | 0 | 0 | 92,26 % |
Azione B | 1 | 33 607 490 | 33 241 120 ( 98,91 %) | 0 |
Coordinate società
Longboard Pharmaceuticals, Inc.
4275 Executive Square Suite 950
92037, La Jolla
+
http://www.longboardpharma.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+264,18% | 828 Mln | |
-1,17% | 102 Mrd | |
+2,87% | 96,09 Mrd | |
+2,13% | 22,28 Mrd | |
-14,77% | 21,4 Mrd | |
-8,79% | 18,14 Mrd | |
-39,98% | 17,02 Mrd | |
-13,21% | 16,09 Mrd | |
+8,55% | 13,83 Mrd | |
+35,75% | 11,97 Mrd |
- Borsa valori
- Azioni
- Azione LBPH
- Società Longboard Pharmaceuticals, Inc.